Correlation Between ATRYS HEALTH and Arrowhead Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ATRYS HEALTH and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATRYS HEALTH and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATRYS HEALTH SA and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on ATRYS HEALTH and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATRYS HEALTH with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATRYS HEALTH and Arrowhead Pharmaceuticals.

Diversification Opportunities for ATRYS HEALTH and Arrowhead Pharmaceuticals

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between ATRYS and Arrowhead is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding ATRYS HEALTH SA and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and ATRYS HEALTH is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATRYS HEALTH SA are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of ATRYS HEALTH i.e., ATRYS HEALTH and Arrowhead Pharmaceuticals go up and down completely randomly.

Pair Corralation between ATRYS HEALTH and Arrowhead Pharmaceuticals

Assuming the 90 days horizon ATRYS HEALTH is expected to generate 5.16 times less return on investment than Arrowhead Pharmaceuticals. But when comparing it to its historical volatility, ATRYS HEALTH SA is 2.63 times less risky than Arrowhead Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Arrowhead Pharmaceuticals is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  1,747  in Arrowhead Pharmaceuticals on September 19, 2024 and sell it today you would earn a total of  363.00  from holding Arrowhead Pharmaceuticals or generate 20.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

ATRYS HEALTH SA  vs.  Arrowhead Pharmaceuticals

 Performance 
       Timeline  
ATRYS HEALTH SA 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in ATRYS HEALTH SA are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, ATRYS HEALTH may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Arrowhead Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Arrowhead Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, Arrowhead Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

ATRYS HEALTH and Arrowhead Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ATRYS HEALTH and Arrowhead Pharmaceuticals

The main advantage of trading using opposite ATRYS HEALTH and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATRYS HEALTH position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.
The idea behind ATRYS HEALTH SA and Arrowhead Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance